BGBIO.OL
Price:
$7.22
Market Cap:
$282.21M
BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of drugs to treat immune evasive, drug resistant, and metastatic cancers; and respiratory diseases. Its lead candidate is Bemcentinib, a bio-available small molecule AXL inhibitor, which is in Phase II clinical development in major cancer indications and COVID-19. Its Phase II clinical trial program focuses on treatment of non-small cell lung cancer, acute myeloid leukaemia, and myelodysplastic syndrome, as well as COVID-19. In addition, it is developing tilvestamab, an anti-AXL antibody that is in Phase Ib clinical trial. BerGenBio ASA has a collaboration agreement with Merck & Co. for clinical trials. The com...[Read more]
Industry
Biotechnology
IPO Date
2017-04-07
Stock Exchange
OSL
Ticker
BGBIO.OL
According to BerGenBio ASA’s latest financial reports and current stock price. The company's current Enterprise Value is 82.09M. This represents a change of -69.20% compared to the average of 266.50M of the last 4 quarters.
The mean historical Enterprise Value of BerGenBio ASA over the last ten years is 1.01B. The current 82.09M Enterprise Value has changed 713.13% with respect to the historical average. Over the past ten years (40 quarters), BGBIO.OL's Enterprise Value was at its highest in in the December 2020 quarter at 2.09B. The Enterprise Value was at its lowest in in the June 2023 quarter at -197032221.80.
Average
1.01B
Median
1.12B
Minimum
275.99M
Maximum
1.69B
Discovering the peaks and valleys of BerGenBio ASA Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 89.34%
Maximum Annual Enterprise Value = 1.69B
Minimum Annual Increase = -62.04%
Minimum Annual Enterprise Value = 275.99M
Year | Enterprise Value | Change |
---|---|---|
2023 | 275.99M | -46.13% |
2022 | 512.30M | -62.04% |
2021 | 1.35B | -20.33% |
2020 | 1.69B | 45.91% |
2019 | 1.16B | 3.49% |
2018 | 1.12B | 89.34% |
2017 | 592.43M | -46.16% |
2016 | 1.10B | -6.05% |
2015 | 1.17B | 4.84% |
The current Enterprise Value of BerGenBio ASA (BGBIO.OL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
712.59M
5-year avg
998.50M
10-year avg
1.01B
BerGenBio ASA’s Enterprise Value is less than Targovax ASA (123.92M), greater than PCI Biotech Holding ASA (31.05M), less than Photocure ASA (1.31B), less than IDEX Biometrics ASA (170.76M), less than XXL ASA (2.22B),
Company | Enterprise Value | Market cap |
---|---|---|
123.92M | $123.47M | |
31.05M | $61.59M | |
1.31B | $1.44B | |
170.76M | $153.03M | |
2.22B | $1.32B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BerGenBio ASA using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BerGenBio ASA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is BerGenBio ASA's Enterprise Value?
What is the highest Enterprise Value for BerGenBio ASA (BGBIO.OL)?
What is the 3-year average Enterprise Value for BerGenBio ASA (BGBIO.OL)?
What is the 5-year average Enterprise Value for BerGenBio ASA (BGBIO.OL)?
How does the current Enterprise Value for BerGenBio ASA (BGBIO.OL) compare to its historical average?